Anpario plc (AIM:ANP)

Market Cap	104.01M +9.4%
Revenue (ttm)	43.93M +34.3%
Net Income	5.15M +70.4%
EPS	0.30 +65.5%
Shares Out	20.60M
PE Ratio	16.98
Forward PE	12.95
Dividend	0.12 (2.27%)
Ex-Dividend Date	Nov 13, 2025

Volume	3,372
Average Volume	28,910
Open	505.00
Previous Close	505.00
Day's Range	492.10 - 510.00
52-Week Range	286.00 - 580.00
Beta	0.92
RSI	36.09
Earnings Date	Mar 31, 2026

About Anpario

Anpario plc, together with its subsidiaries, manufactures and distributes natural animal feed additives for animal health, nutrition, and biosecurity. Its health and performance category offers various products that support and maintain animal gut health, including phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; and feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzy...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1996
• Employees: 157
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: ANP

Financial Performance

In 2024, Anpario's revenue was 38.20 million, an increase of 23.22% compared to the previous year's 31.00 million. Earnings were 4.11 million, an increase of 62.66%.